NEW YORK, March 30 (Reuters Breakingviews) - Concise insights on global finance in the Covid-19 era.
BLACKROCK’S DELIGHT. Nobody in financial markets really likes to see a meltdown like Archegos Capital Management’s over the weekend read more . But the implosion of Bill Hwang’s family office – essentially a private hedge fund – is nonetheless handy ammunition for BlackRock (BLK.N).
Larry Fink’s $8.7 trillion asset manager has long argued it isn’t significantly risky for the financial system despite its massive size. Rather, BlackRock reckons regulators should worry about individual funds, such as Archegos. Wall Street scourge Senator Elizabeth Warren isn’t convinced, asking last week whether Fink's company should be designated a systemically important financial institution read more .
In its defense, BlackRock can point to several historical debacles involving individual hedge funds that borrowed too much, like the collapse of Long-Term Capital Management in 1998. With Archegos, which couldn’t meet margin calls on highly leveraged contracts relating to stocks like ViacomCBS, there's an example that’s bang up-to-date. The fund's woes forced sales by counterparties, landing Credit Suisse, Nomura and others with big losses . That’s what you call systemic. (By Richard Beales)
On Twitter http://twitter.com/breakingviews
Earlier in Capital Calls:
One SPAC's numerous overambitions read more
UniCredit pays up for its next CEO
Turkish central bank revolving door hurts lira
Sberbank’s JV woes stress its own tech challenge
German wage hike is step backwards
- SIGN UP FOR BREAKINGVIEWS EMAIL ALERTS http://bit.ly/BVsubscribe
Reuters Breakingviews is the world's leading source of agenda-setting financial insight. As the Reuters brand for financial commentary, we dissect the big business and economic stories as they break around the world every day. A global team of about 30 correspondents in New York, London, Hong Kong and other major cities provides expert analysis in real time.
Sign up for a free trial of our full service at https://www.breakingviews.com/trial and follow us on Twitter @Breakingviews and at www.breakingviews.com. All opinions expressed are those of the authors.